Literature DB >> 8097120

Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions.

D Kirchhofer1, K S Sakariassen, M Clozel, T B Tschopp, P Hadváry, Y Nemerson, H R Baumgartner.   

Abstract

Endothelial cell-mediated coagulation and leukocyte adhesion are processes that might be connected by the generation of thrombin. To examine the interaction of procoagulant and proadhesive activity, cultures of endothelial cells were stimulated with tumor necrosis factor-alpha, which resulted in the surface expression of tissue factor. Subsequent exposure to human nonanticoagulated blood at a shear rate of 100 s-1 in a parallel plate perfusion device led to the deposition of polymerized fibrin, which covered 63% of the endothelial surface. In addition, numerous platelet aggregates (71 per 10 mm cross-section) and leukocytes (53 +/- 6/mm2) were deposited on stimulated endothelial cells, whereas no fibrin and only a few platelet aggregates (4 +/- 1 per 10 mm cross-section) and leukocytes (6 +/- 1/mm2) were detected on control cells. A significant portion of the adherent leukocytes bound to fibrin and platelets. However, when the deposition of fibrin and platelet aggregates was inhibited with the anti-tissue factor antibody HTFI-7B8 by 100% and 86%, respectively, leukocyte adherence remained unchanged (68 +/- 6/mm2). This indicated that leukocytes could efficiently adhere to endothelial cells through direct cell-cell contact independent of both thrombin and deposited fibrin. Moreover, this direct adhesion of leukocytes to the endothelial surface was reduced twofold to threefold when fibrin deposition occurred. These data suggest a relationship between endothelial procoagulant and proadhesive properties in that tissue factor-initiated coagulation may contribute to leukocyte adhesion through the formation of an adhesive fibrin/platelet meshwork but concurrently prevents the adhesive endothelial surface to bind leukocytes at its full capacity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097120

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  A synthetic selective inhibitor of factor Xa, DX-9065a, reduces monocyte chemoattractant protein-1 expression after ischemia-reperfusion injury in rat liver.

Authors:  Y Yamaguchi; K Okabe; J Liang; F Matsumura; H Ohshiro; K Ishihara; T Matsuda; M Takeya; J I Kuratsu; K Mori; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2008-03-05       Impact factor: 12.479

3.  Rapid, transient phosphatidylserine externalization induced in host cells by infection with Chlamydia spp.

Authors:  S R Goth; R S Stephens
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes.

Authors:  Sergiy Yakovlev; Leonid Medved
Journal:  Thromb Res       Date:  2017-11-21       Impact factor: 3.944

5.  Flow rate and fibrin fiber alignment.

Authors:  K C Gersh; K E Edmondson; J W Weisel
Journal:  J Thromb Haemost       Date:  2010-12       Impact factor: 5.824

6.  Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation.

Authors:  A D Schecter; P L Giesen; O Taby; C L Rosenfield; M Rossikhina; B S Fyfe; D S Kohtz; J T Fallon; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 7.  The influence of biomaterials on endothelial cell thrombogenicity.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2007-02-09       Impact factor: 12.479

8.  Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

Authors:  D Kirchhofer; T B Tschopp; P Hadváry; H R Baumgartner
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.

Authors:  Navaneeth Krishna Rajeeva Pandian; Brandon K Walther; Rishi Suresh; John P Cooke; Abhishek Jain
Journal:  Small       Date:  2020-11-17       Impact factor: 13.281

10.  Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver.

Authors:  N Hisama; Y Yamaguchi; K Okajima; M Uchiba; K Murakami; K Mori; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.